Childhood Laryngeal Tumors Treatment (PDQ®)–Health Professional Version

Changes to This Summary (01/31/2019)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Childhood Laryngeal Papillomatosis

Revised text to state that reports with small numbers of patients have documented that in selected cases, the administration of a quadrivalent human papillomavirus (HPV) vaccine can be associated with a complete remission and an increase in the intersurgical interval (cited Mészner et al. as reference 12). Also added text to state that in contrast, other reports have not documented a therapeutic effect of the quadrivalent HPV vaccine (cited Katsuta et al. as reference 13).

This summary is written and maintained by the PDQ Pediatric Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summaryand PDQ® - NCI's Comprehensive Cancer Database pages.

< Previous section
Special Considerations for the Treatment of Children With Cancer

Next section >
About This PDQ Summary